<SEC-DOCUMENT>0000950170-22-017001.txt : 20220812
<SEC-HEADER>0000950170-22-017001.hdr.sgml : 20220812
<ACCEPTANCE-DATETIME>20220812073055
ACCESSION NUMBER:		0000950170-22-017001
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220812
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220812
DATE AS OF CHANGE:		20220812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HCW Biologics Inc.
		CENTRAL INDEX KEY:			0001828673
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				825024477
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40591
		FILM NUMBER:		221157823

	BUSINESS ADDRESS:	
		STREET 1:		2929 N COMMERCE PKWY
		CITY:			MIRAMAR
		STATE:			FL
		ZIP:			33025
		BUSINESS PHONE:		954-842-2024

	MAIL ADDRESS:	
		STREET 1:		2929 N COMMERCE PKWY
		CITY:			MIRAMAR
		STATE:			FL
		ZIP:			33025
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hcwb-20220812.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2022-08-11T20:16:09.8100+00:00 --><!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:hcwb="http://hcwbiologics.com/20220812">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_c07e2b31-ef1d-46bd-857d-f04e4836e019" name="dei:EntityCentralIndexKey" contextRef="C_b5ac2f13-8351-4cc5-8e7e-abea5c7a90fe">0001828673</ix:nonNumeric><ix:nonNumeric id="F_835ce559-0d60-4c8a-b738-fca82e461121" name="dei:AmendmentFlag" contextRef="C_b5ac2f13-8351-4cc5-8e7e-abea5c7a90fe">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="hcwb-20220812.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_b5ac2f13-8351-4cc5-8e7e-abea5c7a90fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001828673</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-12</xbrli:startDate><xbrli:e